Merck, Bionomics team up to develop chronic pain drug

Bionomics and Merck & Co. agreed to collaborate in the discovery and development of novel small molecule candidates for treatment of neuropathic pain and other forms of chronic pain using the latter's ionX drug discovery technology and MultiCore chemistry. The deal grants Merck an option for an exclusive license for one compound. Bionomics could get as much as $172 million in option exercise fees and milestone payments plus sales royalties.

View Full Article in:

Genetic Engineering & Biotechnology News · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA